Carey, Paul D. Vythillingum, Bavanisha Seedat, Soraya Muller, Jacqueline E. Van Ameringen, Michael Stein, Dan J.
(BioMed Central, 2005-01)
Background: Although serotonin reuptake inhibitors are effective in the treatment of OCD, many patients fail to respond to these agents. Growing evidence from open-label and placebo-controlled trials suggests a role for ...